miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression

Heiko F Stahl1, Tanja Fauti, Nina Ullrich

  • 1Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany.

Plos One
|September 25, 2009
PubMed
Abstract